Unfortunate news from Wave Life Science regarding clinical trial on PRECISION – HD 1.
To read the full press release, click here: https://hdsa.org/wp-content/uploads/2021/03/HD-community-letter_PRECISION-results-final.pdf
From: HDSA March 23, 2021: At the Huntington’s Disease Society of America, we are committed to keeping our families informed with the latest news surrounding HD research. Earlier this week, we received heartbreaking news from Roche/Genentech announcing that they are no longer dosing the drug, tominersen, in the GENERATION-HD1 trial. Since the Roche/Genentech announcement, we have gathered information to explain where we are in drug discovery.
To read the full article from Roche/Genentech halting the clinical trial on the drug tominersen, visit: https://hdsa.org/wp-content/uploads/2021/03/Tominersen-programme-update-Community-letter.pdf